P-gp inhibitor Elacridar, Purity ≥98%

Synonym: 143664-11-3; P-gp inhibitor

MDL: MFCD00912604
CAS Number: 143664-11-3
Compound CID: 119373

Product Size

5 mg; 10 mg; 25 mg; 50 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

Elacridar, soluble in warmed DMSO and insoluble in water and ethanol, blocks the action of P-glycoprotein, a key player in drug transport and resistance, thereby enhancing the effectiveness and bioavailability of therapeutic drugs. It targets BCRP and P-gp.

Molecular Weight

563.64

Molecular Formula

C₃₄H₃₃N₃O₅

Targets

BCRP; P-gp

Form

Lyophilized powder

Purity

≥98%

Solubility

Warmed DMSO: 7 mg/mL (12.42 mM); Water: Insoluble; Ethanol: Insoluble

Identity

Confirmed by NMR/HPLC/MS.

Applications

Elacridar is used in drug delivery and pharmacokinetic research to inhibit P-glycoprotein and enhance drug bioavailability.